NetworkNewsBreaks – Zenosense, Inc. (ZENO) Conti
Post# of 53
Zenosense (OTC: ZENO) is an innovative healthcare technology developer engaged in transformational, disruptive medical diagnostic projects. Recently, the company has achieved two major milestones. An article discussing the company’s recent success reads: “Health care technology company Zenosense, Inc. (OTCQB: ZENO) has completed two important milestones recently. The first was a successful second round of quantitative testing for the MIDS detection technology; the technology is core to the development of MIDS Cardiac™, a handheld device to rapidly test for certain cardiac biomarkers at the point of care. The second milestone relates to the company’s uplisting to the OTC Markets Group OTCQB Venture Market. By trading on the OTCQB Venture Market, Zenosense is better positioned to build shareholder value with a goal of enhancing liquidity and achieving fair valuation (http://nnw.fm/P13Vc).”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer